Lower risk for heart failure with new type 2 diabetes drug



The new drug type for type 2 diabetes, SGLT2 inhibitors, are associated with a reduced risk of heart failure and death, as well as of major cardiovascular events, a major Scandinavian registry study led from Karolinska Institutet reports in The BMJ.



Source link

Leave a Reply!

So glad to see you sticking around!

Want to be the first one to receive the new stuff?

Enter your email address below and we'll send you the goodies straight to your inbox.

Thank You For Subscribing!

This means the world to me!

Spamming is not included! Pinky promise.